Eclipsys Corporation (NASDAQ: ECLP), The Outcomes Company ®, today announced that South Nassau Communities Hospital (South Nassau), a 435-bed teaching hospital located in Oceanside, NY, has selected the company’s Sunrise Enterprise™ suite of integrated clinical solutions. South Nassau’s technology initiative, which includes Eclipsys’ leading computerized physician order entry (CPOE) solution, will support creating a unified electronic system throughout departments to transform care delivery processes for safer care, greater efficiency and improved outcomes. The investment in advanced technology also will support South Nassau in its goal to meet the recently finalized “Meaningful Use” requirements of the American Recovery and Reinvestment Act (ARRA) of 2009 to qualify for stimulus funds. South Nassau’s plans call for deployment of Eclipsys’ CPOE solution to support evidence-based practices and clinical decision making, along with the company’s integrated pharmacy solution, Sunrise Pharmacy™. Working in concert via a single database, the solution enables integrated handoffs between clinicians and pharmacists resulting in fewer errors and accelerated time to medication treatment. Deployment of Eclipsys’ clinical documentation solution, e-prescribing and orders reconciliation solutions will contribute to further clinical efficiency, medication safety and care team collaboration. In combination, these new solutions will create a single electronic health record (EHR) across care venues to improve care team efficiency and clinical decision making. “This significant technology initiative continues our unwavering commitment to provide the highest quality healthcare services to our community,” said John Mertz, chief information officer at South Nassau. “We believe that technology will continue to exponentially replace healthcare’s dependence on paper-based, manual processes. Eclipsys’ proven track record in helping clients achieve deep physician adoption of its systems gave us confidence we chose the right technology partner as an essential step toward providing truly excellent patient care and to meet the expected meaningful use requirements by specified timelines.” Partnering with a Leader in CPOE to Meet Meaningful Use The Center for Medicare and Medicaid Services’(CMS) final rule on ‘meaningful use’ of an EHR includes the requirement that at least 30 percent of a hospital’s patients with a medication order must have that order entered through a CPOE solution. In Stage 2 of ‘meaningful use,’ scheduled to occur in 2013, the percentage of CPOE medication orders requirement doubles to 60 percent. Eclipsys estimates its U.S. client base has achieved on average a 70-percent CPOE adoption rate. In fact, according to the 2010 CPOE study entitled “CPOE: Traffic Jams on the Road to Meaningful Use” issued by KLAS Enterprises, LLC, Eclipsys is recognized as a leader in CPOE and among the most ‘meaningful use-ready’ vendors. In the same report, Eclipsys was recognized as having the greatest percentage of its client base live with CPOE, highest customer satisfaction with CPOE, and greatest percentage of significant or deep physician CPOE users in recently live hospitals.